Empresa Lipella Pharmaceuticals Inc.
Acciones
LIPO
US53630L1008
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,4497 USD | -4,52 % |
|
-30,17 % | -55,91 % |
Resumen de negocios
Número de empleados: 6
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biopharmaceuticals
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +144,15 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +144,15 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 67 | 01/01/05 | |
Jonathan Kaufman
CEO | Chief Executive Officer | 58 | 01/01/05 |
Douglas Johnston
DFI | Director of Finance/CFO | 40 | 01/10/21 |
Janet Okonski
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/21 |
Joseph Janicki
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michelle Gruber
COO | Chief Operating Officer | - | 01/01/09 |
Katie Johnston
AUD | Comptroller/Controller/Auditor | - | - |
Allison Houck
PRN | Corporate Officer/Principal | - | - |
Tomohiro Ueda
PRN | Corporate Officer/Principal | - | - |
Robert Moldwin
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jonathan Kaufman
CEO | Chief Executive Officer | 58 | 01/01/05 |
Founder | 67 | 01/01/05 | |
Byong Kim
BRD | Director/Board Member | 54 | 01/03/22 |
Ryan Pruchnic
BRD | Director/Board Member | 50 | 01/09/21 |
Naoki Yoshimura
BRD | Director/Board Member | 67 | 01/09/21 |
Daniel Cohen
BRD | Director/Board Member | 60 | 21/03/23 |
Lori Birder
BRD | Director/Board Member | 64 | 17/06/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 7 605 636 | 4 520 361 ( 59,43 %) | 0 | 59,43 % |
Información de la empresa
Lipella Pharmaceuticals, Inc.
7800 Susquehanna Street Suite 505
15208, Pittsburgh
+412-901-0315
http://www.lipella.com![Dirección Lipella Pharmaceuticals Inc.(LIPO)](https://cdn.zonebourse.com/static/address/148356418.png)
Sector
![Consenso](/images/consensus_flch.gif)
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-55,91 % | 3,42 M | |
+16,13 % | 122 mil M | |
+19,65 % | 113 mil M | |
+21,22 % | 26,49 mil M | |
-23,84 % | 19,4 mil M | |
-17,47 % | 16,24 mil M | |
-45,95 % | 15,15 mil M | |
-19,28 % | 15,4 mil M | |
+63,81 % | 14,93 mil M | |
+1,94 % | 13,52 mil M |
- Bolsa de valores
- Acciones
- Acción LIPO
- Empresa Lipella Pharmaceuticals Inc.